• Accessibility statement
  • Homepage
  • Sitemap
  • Search
  • Contact
  • Print
Boehringer-Ingelheim Logo
Value through Innovation

Help

jump to main navigationjump to content
  • Home
  • Contact
  • Site Map

main navigation

jump to contentto meta navigation
  • News Centre
  • Corporate Profile
  • Global Activities
  • Research & Development
  • Clinical Trials
  • Products
  • Industrial Customer
  • Careers
Headillustration

page content

jump to main navigationto meta navigation

Top Links

About us

  • Take-away info
  • Financial Highlights
  • Products
  • Corporate Image Video
  • Our Vision
  • Corporate Responsibility
  • Licensing & Partnering

Indication Areas 

  • Benign Prostate Hyperplasia
  • COPD
  • HIV/AIDS
  • Hypertension
  • Parkinson Disease
  • Restless Legs Syndrome
  • Stroke
further areas

Consumer Health Care 

  • Bisolvon®
  • Buscopan®
  • Dulcolax®
  • Mucosolvan®
  • Pharmaton®
further products

Our Businesses

  • Prescription Medicines
  • Consumer Health Care
  • Biopharmaceuticals
  • Pharma Chemicals
  • Pharmaceuticals Production
  • Animal Health

News Resources

  • Press & Information Packs
  • Conference Calendar
  • Media Pool
  • Annual Report
  • Publication Download

Information & Dialogue

  • FAQs - Get the answers
  • Contact - Get in touch
  • RSS
  • Follow us on Twitter

Latest Press Releases

26.07.2010 European Committee for Medicinal Products for Human Use (CHMP) adopts Positive Opinion for TWYNSTA®, Boehringer Ingelheim’s new single pill combination hypertension treatment - For non-US and non-UK Healthcare Media
22.07.2010 VERxVE study demonstrates efficacy and safety of 400mg once daily nevirapine (Viramune®) extended release (NVP XR) formulation
08.07.2010 First PCV-2 / Mycoplasma hyopneumoniae vaccine combination registered in the European Union
Further press releases

VERxVE Study Results

HIV/Aids Teaser
More about Viramune® (nevirapine)

Oncology Website

Oncology White Room
Learn more

Linagliptin Phase III Data

Diabetes webcast banner
View the Webcast

Biopharmaceuticals

Biopharmaceuticals
Read more

Pharma Chemicals

Pharma Chemicals
Read more
No flash player detected. For optimized usage of this website your browser should support shockwave flash. For downloading see Macromedia Flash Player
back to top

Our Global Activities

  • Our Countries A-Z
  • Argentina
  • Austria
  • Australia
  • Bahrain
  • Belarus
  • Belgium
  • Bosnia and Herzegovina
  • Brazil
  • Bulgaria
  • Canada
  • Chile
  • China
  • Colombia
  • Croatia
  • Cyprus
  • Czech Republic
  • Denmark
  • Ecuador
  • Egypt
  • Estonia
  • Ethiopia
  • Finland
  • France
  • Germany
  • Germany Headquarters
  • Greece
  • Ghana
  • Hong Kong
  • Hungary
  • India
  • Indonesia
  • Iraq
  • Irland
  • Israel
  • Italy
  • Japan
  • Jordan
  • Kenya
  • Kuweit
  • Latvia
  • Lebanon
  • Libya
  • Lithuania
  • Macedonia
  • Malawi
  • Malaysia
  • Malta
  • Mauritius
  • Mexico
  • Montenegro
  • The Netherlands
  • New Zealand
  • Nigeria
  • Norway
  • Oman
  • Pakistan
  • Peru
  • The Philippines
  • Poland
  • Portugal
  • Quatar
  • Romania
  • Russia
  • Saudi Arabia
  • Seychelles
  • Serbia
  • Singapore
  • Slovakia
  • Slovenia
  • Somalia
  • South Africa
  • South Korea
  • Spain
  • Sudan
  • Sweden
  • Switzerland
  • Syria
  • Taiwan
  • Tanzania
  • Thailand
  • Turkey
  • USA
  • Uganda
  • Ukraine
  • United Arab Emirates
  • United Kingdom
  • Uruguay
  • Venezuela
  • Vietnam
  • Yemen
for US residents

Bookmarking Services

  • Digg
  • Del.icio.us
  • Google
  • Facebook
  • Technorati

Follow Boehringer Ingelheim 

Teaser Twitter
Follow us on Twitter
© 2010 Boehringer Ingelheim GmbH All rights reserved
  • Print Page
  • Recommend
  • Accessibility Statement
  • Terms of use
  • Imprint
  • RSS Feed